Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Aug 28, 2026

MDGL — Madrigal Pharmaceuticals, Inc. Dilution Risk Tracker

Track MDGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MDGL — Get alerts when the score changes →

As of August 28, 2026, Madrigal Pharmaceuticals, Inc. (MDGL) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Madrigal Pharmaceuticals, Inc. has a market capitalization of $11.46B, 23.10M shares outstanding, 384 institutional holders tracked. Stored dilution-related fields include 4.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
22
💰 Cash Runway
65
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (7mo)
🔔 Track MDGL — Get forecast alerts →

Market Data

Market Cap$11.46B
Shares Outstanding23.10M
Float12.91M
Cash$292.73M
Debt$340.79M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 24.9% shares (2026Q1 vs prior)
384 institutional holders · 30.98M shares
#1 JANUS HENDERSON GROUP PLC 4.04M shares
#2 Avoro Capital Advisors LLC 3.63M shares
#3 BAKER BROS. ADVISORS LP 2.14M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.97M
Days to Cover4.8
% of Float15.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31
xbrl XBRL CONVERTIBLE 2022-05-09
Full SEC filing analysis available with free account

Recent News

No recent news

Factual MDGL Dilution Snapshot

Madrigal Pharmaceuticals, Inc. (MDGL) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track MDGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MDGL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MDGL
MDGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.